Avantax Advisory Services, Inc. Takeda Pharmaceutical CO LTD Transaction History
Avantax Advisory Services, Inc.
- $17.6 Billion
- Q2 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 137,959 shares of TAK stock, worth $1.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
137,959
Previous 114,298
20.7%
Holding current value
$1.89 Million
Previous $1.7 Million
25.49%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
367Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$182 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$104 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$61.7 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$55.2 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$50.9 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...